These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1462887)
1. Activation of kinins on myocardial ischemia. Shimamoto K; Miura T; Miki T; Iimura O Agents Actions Suppl; 1992; 38 ( Pt 3)():90-7. PubMed ID: 1462887 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system. Shimamoto K; Matsuki T; Iimura O J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S83-90. PubMed ID: 1697368 [TBL] [Abstract][Full Text] [Related]
3. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies. Linz W; Wiemer G; Schölkens BA Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801 [TBL] [Abstract][Full Text] [Related]
4. Local inhibition of bradykinin degradation in ischemic hearts. Linz W; Martorana PA; Schölkens BA J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370 [TBL] [Abstract][Full Text] [Related]
5. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479 [TBL] [Abstract][Full Text] [Related]
6. Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA). Zhao L; Kirsch CC; Hagen SR; Elliott GT J Mol Cell Cardiol; 1996 Jan; 28(1):197-208. PubMed ID: 8745227 [TBL] [Abstract][Full Text] [Related]
7. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure. Zhang X; Recchia FA; Bernstein R; Xu X; Nasjletti A; Hintze TH J Pharmacol Exp Ther; 1999 Feb; 288(2):742-51. PubMed ID: 9918584 [TBL] [Abstract][Full Text] [Related]
8. The possible role of bradykinin in the antiischemic activity of ACE-inhibitors. Martorana PA; Schölkens BA Agents Actions Suppl; 1992; 38 ( Pt 3)():98-102. PubMed ID: 1462888 [TBL] [Abstract][Full Text] [Related]
10. [Cardioprotective effects by ramipril after ischemia and reperfusion in animal experiment studies]. Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA Z Kardiol; 1994; 83 Suppl 4():53-6. PubMed ID: 7856280 [TBL] [Abstract][Full Text] [Related]
11. [Alpha-adrenergic control of coronary circulation and left ventricular function during exertion]. Heyndrickx GR; Pannier JL Verh K Acad Geneeskd Belg; 1990; 52(3):225-91. PubMed ID: 1977244 [TBL] [Abstract][Full Text] [Related]
16. The effects of angiotensin-converting enzyme inhibition on coronary blood flow and infarct size limitation. Dargie HJ; Ray SG J Hum Hypertens; 1989 Jun; 3 Suppl 1():101-6. PubMed ID: 2674435 [TBL] [Abstract][Full Text] [Related]
17. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway. Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655 [TBL] [Abstract][Full Text] [Related]
18. The effects of bradykinin and the ischemic isolated rat heart. Tio RA; van Gilst WH; Rett K; Wolters K; Dietze GJ; Wesseling H Horm Metab Res Suppl; 1990; 22():85-9. PubMed ID: 2167866 [TBL] [Abstract][Full Text] [Related]